Search

everythinglearnresearchcommunity

for

Search:↓

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

The conclusion is that a certain test might help find cancer spread in lymph nodes for melanoma patients, but more research is needed due to false positives.

Chemotherapy and radiotherapy improved quality of life and reduced symptoms in lung cancer patients.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Improved collaboration and education between dermatologists and oncologists can enhance care for chemotherapy-related hair loss.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.